The short answer is yes—hexahydrocannabinol (HHC) is legal in West Virginia as of early 2026, but that status rests on a narrow statutory loophole that was altered by the 2026 amendment to the state’s Controlled Substances Act. The change narrows the definition of “synthetic cannabinoids” and clarifies that HHC derived from hemp that meets the 0.3 % Δ⁹‑THC threshold remains unregulated, while products synthesized from non‑hemp sources are now subject to scheduling. In practice, hemp‑derived HHC products can be sold, but manufacturers must tightly control source material and labeling to stay compliant.
Current Legal Landscape
West Virginia’s hemp‑derived cannabinoid regulations were originally modeled on the 2018 Farm Bill, which exempted cannabinoids extracted from industrial hemp containing no more than 0.3 % Δ⁹‑THC (U.S. Code Tit. 7, § 7606). HHC, despite being a hydrogenated form of THC, is not explicitly listed in the schedule of controlled substances, allowing it to fall under the hemp exemption (West Virginia Code § 46‑9‑18). The state’s Department of Health and Human Resources (WVDHHR) has issued guidance that treats HHC like other hemp‑derived cannabinoids, provided the source plant complies with the federal THC limit.
What Changed in 2026?
Effective July 1 2026, West Virginia enacted Senate Bill 322, amending § 46‑9‑18 to add the phrase “synthetically altered cannabinoids derived from non‑hemp sources” to the list of scheduled substances. The amendment was prompted by concerns that some producers were converting CBD into HHC through chemical hydrogenation processes that do not involve hemp biomass (WV Legislature, 2026 Session). Consequently:
- Hemp‑derived HHC remains legal if the raw plant meets the 0.3 % Δ⁹‑THC standard.
- HHC produced via chemical synthesis from isolated cannabinoids or non‑hemp feedstocks is now classified as a Schedule I substance.
- Manufacturers must retain certificates of analysis (COAs) demonstrating hemp origin and THC content below the threshold.
The change closes the “synthetic loophole” while preserving the market for naturally extracted HHC.
Impact on Consumers and Businesses
Retailers can continue to stock HHC tinctures, gummies, and vape cartridges, but they must verify supplier documentation. Failure to provide a valid COA may result in seizure, civil penalties, or criminal charges (West Virginia Controlled Substances Enforcement, 2026). For producers, the amendment encourages a shift toward transparent sourcing and may increase production costs due to testing requirements. Consumers should look for labels that explicitly state “hemp‑derived” and include batch COAs; products lacking this information could be illegal.
Key Takeaways
- HHC is legal in West Virginia only when extracted from hemp that complies with the 0.3 % Δ⁹‑THC limit.
- The 2026 amendment bans synthetically produced HHC from non‑hemp sources.
- Documentation and testing are now mandatory for compliance.
- Retailers and consumers must be vigilant about product provenance to avoid legal risk.
Is HHC considered a controlled substance in West Virginia after the 2026 amendment?
No. HHC remains unscheduled if it is extracted from hemp that meets the 0.3 % Δ⁹‑THC threshold. Synthetic HHC from non‑hemp feedstocks, however, is now classified as Schedule I.
How can retailers verify that an HHC product is hemp‑derived?
Retailers should request a certificate of analysis that shows the hemp source, THC concentration below 0.3 %, and the extraction method. The COA must be dated and signed by an accredited laboratory.
What penalties apply for selling non‑compliant HHC?
Violations can lead to civil fines up to $5,000 per offense, seizure of inventory, and potential criminal prosecution under West Virginia’s controlled substances statutes.
Does the 2026 change affect other cannabinoids like Delta‑8 THC?
Yes. The amendment similarly restricts synthetically produced Delta‑8 THC from non‑hemp sources, aligning its regulatory treatment with HHC.
Are there any federal implications for West Virginia’s HHC rules?
Because the federal Farm Bill still exempts hemp‑derived cannabinoids, West Virginia’s stricter definition does not conflict with federal law, but it does create a more restrictive state environment for producers using synthetic pathways.